Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03389828 · ClinicalTrials.gov registry record

Qualitative Assessment of the Work-Sleep Relationship

A clinical trial of Sleep Health, sponsored by National Institute of Environmental Health Sciences (NIEHS).

Completed
Registry status
263
Enrollment target
2
Study locations

NCT03389828: Completed study of Sleep Health, sponsored by National Institute of Environmental Health Sciences (NIEHS).

NCT03389828 is a study of Sleep Health that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 263 participants, below the 342-participant average among 5 other Sleep Health trials with a reported enrollment target (23% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03389828, a study of Sleep Health, has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).

COMPLETED
Registry status
263 participants
Enrollment target
2
Study locations

Study Summary

Background: Sleep that does not last long and is low-quality is tied to a range of serious health issues. These range from obesity to early death. Research has shown that black people who are professionals or managers are more likely to have this kind of sleep than their white counterparts. Black people are also at higher risk than whites for health problems caused by insufficient sleep. Researchers want to learn more about why these differences exist. Objective: To study reasons for racial differences in the work-sleep relationship. Eligibility: Adults at least 25 years old who: * Are non-Hispanic black or non-Hispanic white * Are employed and work 38 or more hours a week * Live around Raleigh-Durham-Chapel Hill, NC, or Washington, DC Design: Participants will be screened with questions. They will give sociodemographic data like job title, annual income level, and gender. They will give their contact information. Participants will have 1 study visit. They will be in a closed, private conference room. They will join a focus group. The focus groups will be organized by to race, gender, and occupational class. Participants will give informed consent before the focus group begins. During the focus group, participants will be asked about their perceptions of health in general, and their typical work day. They will be asked about sleep. Participants will also fill out a short questionnaire about their job and sleep habits. Focus groups will be audio recorded. The entire session will last 90 to 120 minutes.

Primary Outcome

Data will be analyzed via qualitative coding software to identify themes/patterns in the narratives of participants in focus groups and interviews.

Conditions Studied

Study Locations (2)

Maryland

  • Social and Scientific Systems, Inc. - Silver Spring

North Carolina

  • Social and Scientific Systems, Inc. - Durham

Trial Details

FieldValue
Enrollment Target 263 participants
Start Date 2018-05-08
Est. Completion 2020-09-28

What the finished NCT03389828 record still lists

NCT03389828 is an observational study that tracks outcomes without assigning an intervention. The registered 263 participants enrollment target is mid-sized for trials with a published cap, below the 342-participant average among 5 other Sleep Health trials with a reported enrollment target (23% lower).

The record links to 1 condition, with Sleep Health appearing as the primary indexed condition, and to 0 interventions.

NCT03389828 reports a single indexed study location in Maryland, North Carolina.

Frequently Asked Questions

What is clinical trial NCT03389828 about?

NCT03389828 is a clinical study titled "Qualitative Assessment of the Work-Sleep Relationship". Background: Sleep that does not last long and is low-quality is tied to a range of serious health issues. These range from obesity to early death. Research has shown that black people who are professionals or managers are more likely to have this kind of sleep than their white counterparts. Black p...

What is the current status of trial NCT03389828?

This trial is currently completed. The enrollment target is 263 participants. The study started on 2018-05-08. Estimated completion is 2020-09-28.

What conditions does trial NCT03389828 study?

This clinical trial studies the following conditions: Sleep Health.

Who is sponsoring clinical trial NCT03389828?

This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03389828 being conducted?

This trial has 2 study locations across Maryland, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sleep Health

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04067336 · 263 participants · Phase 1

    First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

  • NCT06234423 · 263 participants · Phase 1

    A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors

  • NCT06724627 · 263 participants · NA

    Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting

  • NCT04101669 · 264 participants · NA

    RESET System Pivotal Trial (Rev F)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03389828, the US trial registry maintained by the National Library of Medicine. NCT03389828 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.